146 related articles for article (PubMed ID: 19448555)
1. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
[TBL] [Abstract][Full Text] [Related]
2. Gadofosveset-enhanced MR angiography of carotid arteries: does steady-state imaging improve accuracy of first-pass imaging? Comparison with selective digital subtraction angiography.
Anzidei M; Napoli A; Marincola BC; Nofroni I; Geiger D; Zaccagna F; Catalano C; Passariello R
Radiology; 2009 May; 251(2):457-66. PubMed ID: 19401574
[TBL] [Abstract][Full Text] [Related]
3. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience.
Nikolaou K; Kramer H; Grosse C; Clevert D; Dietrich O; Hartmann M; Chamberlin P; Assmann S; Reiser MF; Schoenberg SO
Radiology; 2006 Dec; 241(3):861-72. PubMed ID: 17032914
[TBL] [Abstract][Full Text] [Related]
4. MR angiography of infrapopliteal arteries in patients with peripheral arterial occlusive disease by using Gadofosveset at 3.0 T: diagnostic accuracy compared with selective DSA.
Bonel HM; Saar B; Hoppe H; Keo HH; Husmann M; Nikolaou K; Ludwig K; Szucs-Farkas Z; Srivastav S; Kickuth R
Radiology; 2009 Dec; 253(3):879-90. PubMed ID: 19864508
[TBL] [Abstract][Full Text] [Related]
5. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
[TBL] [Abstract][Full Text] [Related]
6. Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium.
Nielsen YW; Eiberg JP; Løgager VB; Hansen MA; Schroeder TV; Thomsen HS
Acad Radiol; 2009 Jun; 16(6):654-61. PubMed ID: 19297207
[TBL] [Abstract][Full Text] [Related]
7. Whole-body magnetic resonance angiography with additional steady-state acquisition of the infragenicular arteries in patients with peripheral arterial disease.
Nielsen YW; Eiberg JP; Løgager VB; Just S; Schroeder TV; Thomsen HS
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):484-91. PubMed ID: 19957180
[TBL] [Abstract][Full Text] [Related]
8. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study.
Rapp JH; Wolff SD; Quinn SF; Soto JA; Meranze SG; Muluk S; Blebea J; Johnson SP; Rofsky NM; Duerinckx A; Foster GS; Kent KC; Moneta G; Middlebrook MR; Narra VR; Toombs BD; Pollak J; Yucel EK; Shamsi K; Weisskoff RM
Radiology; 2005 Jul; 236(1):71-8. PubMed ID: 15987963
[TBL] [Abstract][Full Text] [Related]
9. Supraaortic arteries: contrast-enhanced MR angiography at 3.0 T--highly accelerated parallel acquisition for improved spatial resolution over an extended field of view.
Nael K; Villablanca JP; Pope WB; McNamara TO; Laub G; Finn JP
Radiology; 2007 Feb; 242(2):600-9. PubMed ID: 17255428
[TBL] [Abstract][Full Text] [Related]
10. Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA.
Hadizadeh DR; Gieseke J; Lohmaier SH; Wilhelm K; Boschewitz J; Verrel F; Schild HH; Willinek WA
Radiology; 2008 Nov; 249(2):701-11. PubMed ID: 18769017
[TBL] [Abstract][Full Text] [Related]
11. MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325.
Goyen M; Edelman M; Perreault P; O'Riordan E; Bertoni H; Taylor J; Siragusa D; Sharafuddin M; Mohler ER; Breger R; Yucel EK; Shamsi K; Weisskoff RM
Radiology; 2005 Sep; 236(3):825-33. PubMed ID: 16020554
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation.
Michaely HJ; Attenberger UI; Dietrich O; Schmitt P; Nael K; Kramer H; Reiser MF; Schoenberg SO; Walz M
Invest Radiol; 2008 Sep; 43(9):635-41. PubMed ID: 18708857
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of gadofosveset-enhanced MR angiography for evaluation of pedal arterial disease: multicenter comparative phase 3 study.
Bosch E; Kreitner KF; Peirano MF; Thurnher S; Shamsi K; Parsons EC
AJR Am J Roentgenol; 2008 Jan; 190(1):179-86. PubMed ID: 18094309
[TBL] [Abstract][Full Text] [Related]
14. Imaging the whole body atherosclerosis: high resolution magnetic resonance angiography using blood-pool agent. Initial clinical experience.
Napoli A; Catalano C; Anzidei M; Lanciotti K; Calabrese FA; Cavallo Marincola B; Zini C; Di Paolo PL; Kyventidis T; Passariello R
Minerva Cardioangiol; 2007 Jun; 55(3):291-301. PubMed ID: 17534247
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.
Iezzi R; Soulez G; Thurnher S; Schneider G; Kirchin MA; Shen N; Pirovano G; Spinazzi A
Eur J Radiol; 2011 Feb; 77(2):358-68. PubMed ID: 19679417
[TBL] [Abstract][Full Text] [Related]
16. Pedal angiography in peripheral arterial occlusive disease: first-pass i.v. contrast-enhanced MR angiography with blood pool contrast medium versus intraarterial digital subtraction angiography.
Kos S; Reisinger C; Aschwanden M; Bongartz GM; Jacob AL; Bilecen D
AJR Am J Roentgenol; 2009 Mar; 192(3):775-84. PubMed ID: 19234277
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial.
Thurnher S; Miller S; Schneider G; Ballarati C; Bongartz G; Herborn CU; Schoenberg S; Cova MA; Morana G; Niazi K; Iezzi R; Taupitz M; Bluemke DA; Kreitner KF; Kirchin MA; Pirovano G
AJR Am J Roentgenol; 2007 Nov; 189(5):1223-37. PubMed ID: 17954665
[TBL] [Abstract][Full Text] [Related]
18. Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis.
Leiner T; Kessels AG; Nelemans PJ; Vasbinder GB; de Haan MW; Kitslaar PE; Ho KY; Tordoir JH; van Engelshoven JM
Radiology; 2005 May; 235(2):699-708. PubMed ID: 15858107
[TBL] [Abstract][Full Text] [Related]
19. Ultrafast whole-body MR angiography with two-dimensional parallel imaging at 3.0 T: feasibility study.
Fenchel M; Doering J; Seeger A; Kramer U; Rittig K; Klumpp B; Claussen CD; Miller S
Radiology; 2009 Jan; 250(1):254-63. PubMed ID: 19001152
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic performance of contrast-enhanced MR angiography of the aortoiliac arteries with the blood pool agent Vasovist: initial results in comparison to intra-arterial DSA].
Vogt FM; Herborn CU; Parsons EC; Kröger K; Barkhausen J; Goyen M
Rofo; 2007 Apr; 179(4):412-20. PubMed ID: 17385136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
